Brief: Invivo Therapeutics Says Co Anticipates Enrolling First Patient In Inspire 2.0 Study In Q1 2019
04/01/2019 21:56
Jan 4 (Reuters) - InVivo Therapeutics Holdings Corp
NVIV.O :
* INVIVO THERAPEUTICS SAYS CO ANTICIPATES ENROLLING FIRST
PATIENT
IN INSPIRE 2.0 STUDY IN Q1 2019 - SEC FILING
Source text: (https://bit.ly/2R6bdlY)
Further company coverage: NVIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InVivo Therapeutics Holdings
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
InVivo Therapeutics falls on filing for Chapter 11 bankruptcy
Brief: InVivo Therapeutics Holdings Received Notice Of Delisting Or Failure To Satisfy Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR